cpaniselloPhD's profile picture. PhD Student in Biomedicine 🔬💊📚✏️ @Menendez_Lab @CarrerasIJC
Studying potential immunotherapies for the treatment of Ewing Sarcoma.

Carla Panisello

@cpaniselloPhD

PhD Student in Biomedicine 🔬💊📚✏️ @Menendez_Lab @CarrerasIJC Studying potential immunotherapies for the treatment of Ewing Sarcoma.

Congrats! You deserve it!

So proud of Aida Falgàs @aidafc8 from @CarrerasIJC and Javi Arroyo @jarroyo8 from @CNIOStopCancer for being awarded tha best paper from the @jitcancer @sitcancer on next generation CART!

Menendez_Lab's tweet image. So proud of Aida Falgàs @aidafc8 from @CarrerasIJC and Javi Arroyo @jarroyo8 from @CNIOStopCancer for being awarded tha best paper from the @jitcancer @sitcancer on next generation CART!


Carla Panisello reposted

Huge congratulations to our researcher Maria Cadefau, from @sergicuartero's lab, for successfully defending her PhD thesis “Mechanisms of transcriptional regulation by CEBPA isoforms.” 🧬🎓 An outstanding project and presentation ✨ Well done, Dr Cadefau!

CarrerasIJC's tweet image. Huge congratulations to our researcher Maria Cadefau, from @sergicuartero's lab, for successfully defending her PhD thesis “Mechanisms of transcriptional regulation by CEBPA isoforms.” 🧬🎓

An outstanding project and presentation ✨ Well done, Dr Cadefau!

Carla Panisello reposted

Sant Joan de Déu i @carrerasijc creen un programa de recerca en leucèmia infantil 💪 Aquest projecte de més de 10M€ inclourà un nou laboratori en el SJD Pediatric Cancer Center Barcelona amb fins a 8 equips de recerca. 👉 Més informació: bit.ly/3IDidmd

SJDbarcelona_ca's tweet image. Sant Joan de Déu i @carrerasijc creen un programa de recerca en leucèmia infantil 💪

Aquest projecte de més de 10M€ inclourà un nou laboratori en el SJD Pediatric Cancer Center Barcelona amb fins a 8 equips de recerca.

👉 Més informació: bit.ly/3IDidmd

Carla Panisello reposted

🩺Los investigadores han desarrollado una innovadora terapia CAR-T dual contra la leucemia linfoblástica aguda de células T. 📻Escucha la entrevista con el Dr. Pablo Menéndez (@Menendez_Lab ), del @CarrerasIJC en @ree_rne Aquí ⤵️ rtve.es/play/audios/a-…


Carla Panisello reposted

Thrilled to see our latest study published! 🚀 We present a novel dual immunotherapy approach for T-ALL. Huge thanks to the amazing team @Menendez_Lab and all collaborators who made this possible, @ToribioLab @onechaintx and others! 🔗 link.springer.com/article/10.118…


Carla Panisello reposted

¡Avances en inmunoterapia para la leucemia infantil! Una nueva inmunoterapia para la leucemia infantil más frecuente demuestra su eficacia en modelos animales ✳️Enhorabuena al Dr @Alvarez_Vallina y equipos @H12Octubre @CNIOStopCancer @CarrerasIJC

ContraCancerSCT's tweet image. ¡Avances en inmunoterapia para la leucemia infantil! Una nueva inmunoterapia para la leucemia infantil más frecuente demuestra su eficacia en modelos animales
✳️Enhorabuena al Dr @Alvarez_Vallina y equipos @H12Octubre @CNIOStopCancer @CarrerasIJC

Carla Panisello reposted

📢 Big news from #EHA2025! @MerGuMu (@Menendez_Lab) has been awarded an @EHA_Hematology Research Mobility Grant ✈️🌍 to join the @sangerinstitute @wellcomegenome in #Cambridge for her PhD stay🔬 An incredible opportunity to push forward her research in blood cancers 👏

CarrerasIJC's tweet image. 📢 Big news from #EHA2025!

@MerGuMu (@Menendez_Lab) has been awarded an @EHA_Hematology Research Mobility Grant ✈️🌍 to join the @sangerinstitute @wellcomegenome in #Cambridge for her PhD stay🔬 

An incredible opportunity to push forward her research in blood cancers 👏
CarrerasIJC's tweet image. 📢 Big news from #EHA2025!

@MerGuMu (@Menendez_Lab) has been awarded an @EHA_Hematology Research Mobility Grant ✈️🌍 to join the @sangerinstitute @wellcomegenome in #Cambridge for her PhD stay🔬 

An incredible opportunity to push forward her research in blood cancers 👏

Carla Panisello reposted

From Barcelona to Milan ✈️ Proud of our IJC delegation attending #EHA2025! 👏 @EHA_Hematology

CarrerasIJC's tweet image. From Barcelona to Milan ✈️

Proud of our IJC delegation attending #EHA2025! 👏

@EHA_Hematology

Que bien poder ser participe de este proyecto! Gracias @FundacionFero @FundAladina por el apoyo! Seguimos! 👩🏼‍🔬💪🏿

El Dr. Pablo Menéndez (@Menendez_Lab), investigador del Instituto de Investigación contra la Leucemia Josep Carreras (@CarrerasIJC), ha recibido la I Beca FERO-Aladina (@FundAladina) en cáncer pediátrico. 🙌🏻 ¡Enhorabuena, Dr. Menéndez! #GalaBenéfica #BecasFERO #Ganadores

FundacionFero's tweet image. El Dr. Pablo Menéndez (@Menendez_Lab), investigador del Instituto de Investigación contra la Leucemia Josep Carreras (@CarrerasIJC), ha recibido la I Beca FERO-Aladina (@FundAladina) en cáncer pediátrico. 🙌🏻

¡Enhorabuena, Dr. Menéndez!

#GalaBenéfica #BecasFERO  #Ganadores
FundacionFero's tweet image. El Dr. Pablo Menéndez (@Menendez_Lab), investigador del Instituto de Investigación contra la Leucemia Josep Carreras (@CarrerasIJC), ha recibido la I Beca FERO-Aladina (@FundAladina) en cáncer pediátrico. 🙌🏻

¡Enhorabuena, Dr. Menéndez!

#GalaBenéfica #BecasFERO  #Ganadores
FundacionFero's tweet image. El Dr. Pablo Menéndez (@Menendez_Lab), investigador del Instituto de Investigación contra la Leucemia Josep Carreras (@CarrerasIJC), ha recibido la I Beca FERO-Aladina (@FundAladina) en cáncer pediátrico. 🙌🏻

¡Enhorabuena, Dr. Menéndez!

#GalaBenéfica #BecasFERO  #Ganadores


Few weeks ago I visited the @HansClevers group in @prinsesmaximac! It was great to learn about Ewing Sarcoma organoids and how to use them as a tool to test new immunotherapies! Thanks to all the team, specilly to Elisabetta Liuzzi and @Karin_Sanders_ #ewingsarcoma #organoids 👩🏼‍🔬

cpaniselloPhD's tweet image. Few weeks ago I visited the @HansClevers group in @prinsesmaximac! It was great to learn about Ewing Sarcoma organoids and how to use them as a tool to test new immunotherapies! Thanks to all the team, specilly to Elisabetta Liuzzi and @Karin_Sanders_ #ewingsarcoma #organoids 👩🏼‍🔬
cpaniselloPhD's tweet image. Few weeks ago I visited the @HansClevers group in @prinsesmaximac! It was great to learn about Ewing Sarcoma organoids and how to use them as a tool to test new immunotherapies! Thanks to all the team, specilly to Elisabetta Liuzzi and @Karin_Sanders_ #ewingsarcoma #organoids 👩🏼‍🔬
cpaniselloPhD's tweet image. Few weeks ago I visited the @HansClevers group in @prinsesmaximac! It was great to learn about Ewing Sarcoma organoids and how to use them as a tool to test new immunotherapies! Thanks to all the team, specilly to Elisabetta Liuzzi and @Karin_Sanders_ #ewingsarcoma #organoids 👩🏼‍🔬

Carla Panisello reposted

🔵 El Dr. Pablo Menéndez recibe la Beca @FundacionFero-@FundAladina en cáncer pediátrico 🔬 Gracias a esta ayuda el @Menendez_Lab trabajará en el desarrollo de una inmunoterapia más efectiva y menos tóxica, reforzada con células CAR-T, para tratar sarcomas pediátricos. ➡️…

CarrerasIJC's tweet image. 🔵 El Dr. Pablo Menéndez recibe la Beca @FundacionFero-@FundAladina en cáncer pediátrico

🔬 Gracias a esta ayuda el @Menendez_Lab trabajará en el desarrollo de una inmunoterapia más efectiva y menos tóxica, reforzada con células CAR-T, para tratar sarcomas pediátricos.

➡️…

Carla Panisello reposted

🔬 Researchers led by @aidafc8 (@Menendez_Lab) and @jarroyo8 (@H12Octubre @CNIOStopCancer) have developed a novel dual-action CAR-T therapy for B-ALL, combining CD22 targeting with a secreted CD19 T-cell engager. ✅ This new approach enhances immune response and reduces relapse…

CarrerasIJC's tweet image. 🔬 Researchers led by @aidafc8 (@Menendez_Lab) and @jarroyo8 (@H12Octubre @CNIOStopCancer) have developed a novel dual-action CAR-T therapy for B-ALL, combining CD22 targeting with a secreted CD19 T-cell engager. 

✅ This new approach enhances immune response and reduces relapse…

Carla Panisello reposted

Gracias @FundacionFero y @FundAladina x apoyar a nuestro equipo @cpaniselloPhD @clarabueno_74 a llevar este trabajo a clinica

Ganador de la I Beca FERO - Aladina en cáncer pediátrico Felicidades Dr. @Menendez_Lab @FundAladina @CarrerasIJC #cancerpediatrico #becasFERO

FundacionFero's tweet image. Ganador de la I Beca FERO - Aladina en cáncer pediátrico
Felicidades Dr. @Menendez_Lab 
@FundAladina @CarrerasIJC #cancerpediatrico #becasFERO
FundacionFero's tweet image. Ganador de la I Beca FERO - Aladina en cáncer pediátrico
Felicidades Dr. @Menendez_Lab 
@FundAladina @CarrerasIJC #cancerpediatrico #becasFERO


It's such a great honor to be part of this team! Happy that our effort is being valued by @FundAladina and @FundacionFero ! We will keep working for the fight against paediatric cancer! 👩🏼‍🔬👩🏼‍🔬👩🏼‍🔬 @Menendez_Lab @clarabueno_74

Ganador de la I Beca FERO - Aladina en cáncer pediátrico Felicidades Dr. @Menendez_Lab @FundAladina @CarrerasIJC #cancerpediatrico #becasFERO

FundacionFero's tweet image. Ganador de la I Beca FERO - Aladina en cáncer pediátrico
Felicidades Dr. @Menendez_Lab 
@FundAladina @CarrerasIJC #cancerpediatrico #becasFERO
FundacionFero's tweet image. Ganador de la I Beca FERO - Aladina en cáncer pediátrico
Felicidades Dr. @Menendez_Lab 
@FundAladina @CarrerasIJC #cancerpediatrico #becasFERO


Carla Panisello reposted

We thank @ACIR_org for highlighting our paper, 'CD22 CAR-T cells secreting CD19 T-cell engagers for improved control of B-cell acute lymphoblastic leukaemia progression' published in @jitcancer, co-authored by @jarroyo8 @H12Octubre @CNIOStopCancer & @aidafc8 @CarrerasIJC

To minimize tumor antigen loss and reduce the risk of CD19+ leukemia progression in r/r B-ALL, Arroyo-Ródenas ‍and Falgas et al. developed dual-targeted CD22 CAR T cells secreting an anti-CD19 T cell-engaging antibody (CAR-STAb-T). bit.ly/4mhBc4K  @Alvarez_Vallina

ACIR_org's tweet image. To minimize tumor antigen loss and reduce the risk of CD19+ leukemia progression in r/r B-ALL, Arroyo-Ródenas ‍and Falgas et al. developed dual-targeted CD22 CAR T cells secreting an anti-CD19 T cell-engaging antibody (CAR-STAb-T). bit.ly/4mhBc4K  @Alvarez_Vallina


It was great to be part of the Workshop and learn so many new models to test immunotherapies in vivo! #immunomodel #cost

⚗️Workshop: Harmonizing In Vivo Models of Immunotherapy was a great success! Great energy and thoughtful discussion at the Workshop in Bergen, where 53 participants explored how #invivomodels can drive progress in #immunotherapy. 👏 Huge thanks to organizers #COST

immunomodel's tweet image. ⚗️Workshop: Harmonizing In Vivo Models of Immunotherapy was a great success!

Great energy and thoughtful discussion at the Workshop in Bergen, where 53 participants explored how #invivomodels can drive progress in #immunotherapy.

👏 Huge thanks to organizers

#COST
immunomodel's tweet image. ⚗️Workshop: Harmonizing In Vivo Models of Immunotherapy was a great success!

Great energy and thoughtful discussion at the Workshop in Bergen, where 53 participants explored how #invivomodels can drive progress in #immunotherapy.

👏 Huge thanks to organizers

#COST
immunomodel's tweet image. ⚗️Workshop: Harmonizing In Vivo Models of Immunotherapy was a great success!

Great energy and thoughtful discussion at the Workshop in Bergen, where 53 participants explored how #invivomodels can drive progress in #immunotherapy.

👏 Huge thanks to organizers

#COST
immunomodel's tweet image. ⚗️Workshop: Harmonizing In Vivo Models of Immunotherapy was a great success!

Great energy and thoughtful discussion at the Workshop in Bergen, where 53 participants explored how #invivomodels can drive progress in #immunotherapy.

👏 Huge thanks to organizers

#COST


Carla Panisello reposted

⚗️Workshop: Harmonizing In Vivo Models of Immunotherapy was a great success! Great energy and thoughtful discussion at the Workshop in Bergen, where 53 participants explored how #invivomodels can drive progress in #immunotherapy. 👏 Huge thanks to organizers #COST

immunomodel's tweet image. ⚗️Workshop: Harmonizing In Vivo Models of Immunotherapy was a great success!

Great energy and thoughtful discussion at the Workshop in Bergen, where 53 participants explored how #invivomodels can drive progress in #immunotherapy.

👏 Huge thanks to organizers

#COST
immunomodel's tweet image. ⚗️Workshop: Harmonizing In Vivo Models of Immunotherapy was a great success!

Great energy and thoughtful discussion at the Workshop in Bergen, where 53 participants explored how #invivomodels can drive progress in #immunotherapy.

👏 Huge thanks to organizers

#COST
immunomodel's tweet image. ⚗️Workshop: Harmonizing In Vivo Models of Immunotherapy was a great success!

Great energy and thoughtful discussion at the Workshop in Bergen, where 53 participants explored how #invivomodels can drive progress in #immunotherapy.

👏 Huge thanks to organizers

#COST
immunomodel's tweet image. ⚗️Workshop: Harmonizing In Vivo Models of Immunotherapy was a great success!

Great energy and thoughtful discussion at the Workshop in Bergen, where 53 participants explored how #invivomodels can drive progress in #immunotherapy.

👏 Huge thanks to organizers

#COST

Carla Panisello reposted

Happy to share our latest work @Menendez_Lab @clarabueno_74 @aidafc8 @CarrerasIJC in collaboration with the @Alvarez_Vallina Lab at @CNIOStopCancer and @H12Octubre on new CD22 and CD19 T cell redirecting strategies spanning CAR &T-cell engagers (STabs). pubmed.ncbi.nlm.nih.gov/40306957/


Carla Panisello reposted

Dr. Olaf Heidenreich (@prinsesmaximac) will deliver a special #InvitedLecture at our Institute — don’t miss it! 🎙️ "AML: a balancing act between proliferation differentiation and self-renewal" 🗓️Wednesday, 7 May 2025, 3pm CEST 📍IJC Auditorium 🔗 Join online at…

CarrerasIJC's tweet image. Dr. Olaf Heidenreich (@prinsesmaximac) will deliver a special #InvitedLecture at our Institute — don’t miss it!

🎙️ "AML: a balancing act between proliferation differentiation and self-renewal"

🗓️Wednesday, 7 May 2025, 3pm CEST
📍IJC Auditorium
🔗 Join online at…

Loading...

Something went wrong.


Something went wrong.